BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 28)

Vulvovaginal candidiasis treatment granted FDA QIDP and Fast Track designations

By

New Jersey based biotechnology company, SCYNEXIS, Inc. announced this week that the U.S. Food and Drug Administration(FDA) has granted both Qualified Infectious Disease Product (QIDP) and Fast Track...

Smallpox antiviral: FDA panel gives OK

By

SIGA Technologies, Inc. (SIGA), a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced this week on a favorable...

Antibiotic-resistant Acinetobacter baumannii infections in children across the US: After 2008, a downward trend reported

By

In the first national study of the prevalence of antibiotic-resistant Acinetobacter baumannii infections in children across the US, researchers from Center for Disease Dynamics, Economics, & Policy...

Anthrax antitoxin purchased for Strategic National Stockpile

By

The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) will purchase an anthrax treatment for $25.2 million from Elusys Therapeutics...

Newly discovered antibiotic class, Odilorhabdins, and how they work

By

Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics. The...

Gonorrhea: UNC researchers identify mutations that could lead to ‘superbug’ strains

By

The bacterium that causes the sexually transmitted disease gonorrhea is resistant to multiple standard antibiotics and now threatens to develop resistance against ceftriaxone, which is on the World Health...

CDC: More than 220 instances of bacteria with ‘unusual’ antibiotic resistance genes in the United States in 2017

By

Health departments working with CDC’s Antibiotic Resistance (AR) Lab Network found more than 220 instances of germs with “unusual” antibiotic resistance genes in the United States last year, according...

Favipiravir in high doses may be effective against Ebola

By

High doses of favipiravir extended survival in non-human primates infected with Ebola virus, according to a new study published this week in PLOS Medicine by Jeremie Guedj of INSERM, France, and colleagues. Despite...

Antibiotic resistance: Low-income and middle-income countries report increases in antibiotic consumption, fueling the problem

By

Despite the threat of a global health crisis in antibiotic resistance, worldwide use of antibiotics in humans soared 39 percent between 2000 and 2015, fueled by dramatic increases in low-income and middle-income...

Antibiotics: Synthesized teixobactin used to treat a bacterial infection in mice

By

A “game changing” new antibiotic which is capable of killing superbugs has been successfully synthesized and used to treat an infection for the first time — and could lead to the first...